ADMINISTRATIVE

行政的

• 批准号: 8254473
• 负责人: D GARY GILLILAND
• 金额: $ 9.07万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2013-03-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8254473
• 关键词: Administrator; Award; Boston; Budgets; Clinical Investigator; Communication; Decision Making; Development; Gender; Grant; Hospitals; Human; Individual; Institution; Israel; Laboratories; Minority; Monitor; Participant; Pediatric Hospitals; Performance; Persons; Preparation; Program Research Project Grants; Progress Reports; Protocols documentation; Regulation; Reporting; Research Personnel; Resource Allocation; Schedule; Services; Site; Specialist; United States National Institutes of Health; Vertebrates; Woman; Work; base; experience; human subject; leukemia; meetings; member; novel therapeutics; operation; programs; protocol development; symposium

The Administrative Core will provide management services to each of the Projects and Cores in this Program. The Core will provide financial, adminstrative, and clerical services for the PI, the Co-Pi, Project Leaders, and Core Leaders for all grant-related activities. These activites include the preparation of this competing renewal, non-competing renewals including progress reports, preparation of budgets, communication with the NIH regarding renewals and all financial interactions, and assurance that the labs supported by this Program are in full compliance with all institutional, state and federal regulations. Core A will also coordinate and scheduling all meetings related to the function of the Program, including monthly meetings of all Project and Core Leaders, and members of their respective laboratories, as well as twice yearly meetings of the Internal and External Advisory Boards. Core A will also coordinate efforts with off-site investiators at the three neighboring institutions, Brigham and Women's Hospital, Beth Israel-Deaconess Hospital, and Children's Hospital of Boston, as well as interaction with the investigators at the DFCI. Dr. Gilliland is the PI and Director of this Core, and will serve as the overall scientific director and chief administrator. Dr. Griffin is the Co-Pi and will assist in these operations, particaulrly with regard to matters with the on-site investigators and clinical programs at the DFCI. He will assist Dr. Gilliland in monitoring protocol performance and will assist in protocol development. Alberto Jamarillo is a highly skilled administrator with experience in management of fiscal and administrative matters for large program project grants. He will serve as Administrative Facilitator, and coordinate Program administration and fiscal oversight with Dr. Gilliland and Dr. Griffin. Alberto Jamarillo will be assisted by Betsy Kelley, a Grants Management Specialist/Post Award, and Mariha Duarte, an administrative assistant, in coordination with Dr. Gilliland and Dr. Griffin, to manage budgets between participating institutions, prepare reports including noncompeting renewals, interface with the financial officers of each participating institution in the Program, and serve as an interface between these groups and the NIH. In addition, the Administrative Core will assure compliance with appropriate regulations regarding experimentation with human subjects, (including gender and minority participation) and vertebrate animals.

行政核心将为本计划中的每个项目和核心提供管理服务。核心将为PI、Co-PI、项目负责人和核心负责人提供所有赠款相关活动的财务、行政和文书服务。这些活动包括准备竞争性更新、非竞争性更新（包括进度报告）、编制预算、与NIH就更新和所有财务互动进行沟通，并确保本计划支持的实验室完全符合所有机构、州和联邦法规。核心A还将协调和安排与本计划职能相关的所有会议，包括所有项目和核心领导人及其各自实验室成员的月度会议，以及内部和外部咨询委员会每年两次的会议。核心A还将与三个邻近机构的场外调查人员协调工作，包括布里格姆妇女医院、贝斯以色列女执事医院和波士顿儿童医院，以及与DFCI调查人员的互动。Gilliland博士是该核心的PI和主任，并将担任总体科学主任和首席管理员。Griffin博士是Co-Pi，将协助这些操作，特别是与DFCI的现场研究者和临床项目有关的事宜。他将协助Dr. Gilliland监测方案执行情况并协助方案制定。Alberto Jamarillo是一位高度熟练的管理人员，在大型项目赠款的财政和行政事务管理方面具有丰富的经验。他将担任行政协调员，并与Gilliland博士和Griffin博士协调项目管理和财政监督。Alberto Jamarillo将由赠款管理专家/职位奖Betsy Kelley和行政助理Mariha Duarte协助，与Gilliland博士和Griffin博士协调，管理参与机构之间的预算，准备报告，包括非竞争性续约，与该计划中每个参与机构的财务官员进行沟通，并担任这些团体与NIH之间的接口。此外，行政核心将确保遵守有关人类受试者（包括性别和少数群体参与）和脊椎动物实验的适当法规。